Annual Total Debt
$15.13 M
-$1.23 M-7.53%
30 June 2024
Summary:
Aytu BioPharma annual total debt is currently $15.13 million, with the most recent change of -$1.23 million (-7.53%) on 30 June 2024. During the last 3 years, it has fallen by -$9.65 million (-38.95%). AYTU annual total debt is now -38.95% below its all-time high of $24.78 million, reached on 30 June 2021.AYTU Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$16.56 M
+$1.43 M+9.44%
30 September 2024
Summary:
Aytu BioPharma quarterly total debt is currently $16.56 million, with the most recent change of +$1.43 million (+9.44%) on 30 September 2024. Over the past year, it has increased by +$438.00 thousand (+2.72%). AYTU quarterly total debt is now -39.95% below its all-time high of $27.57 million, reached on 31 December 2021.AYTU Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AYTU Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.5% | +2.7% |
| 3 y3 years | -39.0% | -33.8% |
| 5 y5 years | +100.0% | +4103.4% |
AYTU Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.0% | at low | -40.0% | +9.4% |
| 5 y | 5 years | -39.0% | -40.0% | +4103.4% | |
| alltime | all time | -39.0% | -40.0% |
Aytu BioPharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.56 M(+9.4%) |
| June 2024 | $15.13 M(-7.5%) | $15.13 M(-9.5%) |
| Mar 2024 | - | $16.72 M(+4.2%) |
| Dec 2023 | - | $16.04 M(-0.5%) |
| Sept 2023 | - | $16.12 M(-1.5%) |
| June 2023 | $16.36 M(-10.0%) | $16.36 M(-34.8%) |
| Mar 2023 | - | $25.09 M(+13.8%) |
| Dec 2022 | - | $22.05 M(-2.3%) |
| Sept 2022 | - | $22.57 M(+24.1%) |
| June 2022 | $18.19 M(-26.6%) | $18.19 M(-14.5%) |
| Mar 2022 | - | $21.26 M(-22.9%) |
| Dec 2021 | - | $27.57 M(+10.2%) |
| Sept 2021 | - | $25.02 M(+1.0%) |
| June 2021 | $24.78 M(+1134.8%) | $24.78 M(-7.6%) |
| Mar 2021 | - | $26.83 M(+2420.4%) |
| Dec 2020 | - | $1.06 M(-44.5%) |
| Sept 2020 | - | $1.92 M(-4.5%) |
| June 2020 | $2.01 M(>+9900.0%) | $2.01 M(-64.5%) |
| Mar 2020 | - | $5.65 M(+786.5%) |
| Dec 2019 | - | $637.60 K(+61.9%) |
| Sept 2019 | - | $393.90 K(>+9900.0%) |
| June 2019 | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2019 | - | $5.13 M(+2.0%) |
| Dec 2018 | - | $5.04 M(>+9900.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2016 | - | $9800.00(-99.8%) |
| Dec 2015 | - | $4.92 M(+2.0%) |
| Sept 2015 | - | $4.83 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Feb 2015 | - | $36.50 K(+14.1%) |
| Nov 2014 | - | $32.00 K(+3.2%) |
| Aug 2014 | $31.00 K(>+9900.0%) | $31.00 K(+8.8%) |
| June 2014 | $0.00(-100.0%) | - |
| May 2014 | - | $28.50 K(-74.8%) |
| Feb 2014 | - | $113.00 K(+7.6%) |
| Nov 2013 | - | $105.00 K(+5.5%) |
| Aug 2013 | $99.50 K(+46.1%) | $99.50 K(+3.5%) |
| May 2013 | - | $96.10 K(+15.4%) |
| Feb 2013 | - | $83.30 K(>+9900.0%) |
| Nov 2012 | - | $0.00(-100.0%) |
| Aug 2012 | $68.10 K(+30.2%) | $68.10 K(+22.9%) |
| May 2012 | - | $55.40 K(>+9900.0%) |
| Feb 2012 | - | $0.00(0.0%) |
| Nov 2011 | - | $0.00(-100.0%) |
| Aug 2011 | $52.30 K(-32.6%) | $52.30 K(-10.6%) |
| May 2011 | - | $58.50 K(>+9900.0%) |
| Feb 2011 | - | $0.00(0.0%) |
| Nov 2010 | - | $0.00(-100.0%) |
| Aug 2010 | $77.60 K(+42.1%) | $77.60 K(>+9900.0%) |
| May 2010 | - | $0.00(0.0%) |
| Feb 2010 | - | $0.00(0.0%) |
| Nov 2009 | - | $0.00(-100.0%) |
| Aug 2009 | $54.60 K(+13.5%) | $54.60 K(>+9900.0%) |
| May 2009 | - | $0.00(0.0%) |
| Feb 2009 | - | $0.00(-100.0%) |
| Nov 2008 | - | $49.40 K(+2.7%) |
| Aug 2008 | $48.10 K(+39.8%) | $48.10 K(+28.3%) |
| May 2008 | - | $37.50 K(+9.0%) |
| Feb 2008 | - | $34.40 K(0.0%) |
| Nov 2007 | - | $34.40 K(0.0%) |
| Aug 2007 | $34.40 K | $34.40 K(0.0%) |
| May 2007 | - | $34.40 K(>+9900.0%) |
| Feb 2007 | - | $0.00(0.0%) |
| Nov 2006 | - | $0.00(0.0%) |
| May 2006 | - | $0.00 |
FAQ
- What is Aytu BioPharma annual total debt?
- What is the all time high annual total debt for Aytu BioPharma?
- What is Aytu BioPharma annual total debt year-on-year change?
- What is Aytu BioPharma quarterly total debt?
- What is the all time high quarterly total debt for Aytu BioPharma?
- What is Aytu BioPharma quarterly total debt year-on-year change?
What is Aytu BioPharma annual total debt?
The current annual total debt of AYTU is $15.13 M
What is the all time high annual total debt for Aytu BioPharma?
Aytu BioPharma all-time high annual total debt is $24.78 M
What is Aytu BioPharma annual total debt year-on-year change?
Over the past year, AYTU annual total debt has changed by -$1.23 M (-7.53%)
What is Aytu BioPharma quarterly total debt?
The current quarterly total debt of AYTU is $16.56 M
What is the all time high quarterly total debt for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total debt is $27.57 M
What is Aytu BioPharma quarterly total debt year-on-year change?
Over the past year, AYTU quarterly total debt has changed by +$438.00 K (+2.72%)